350 related articles for article (PubMed ID: 2846152)
1. Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.
Preis PN; Saya H; Nádasdi L; Hochhaus G; Levin V; Sadée W
Cancer Res; 1988 Nov; 48(22):6530-4. PubMed ID: 2846152
[TBL] [Abstract][Full Text] [Related]
2. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
Voigt A; Zintl F
Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
[TBL] [Abstract][Full Text] [Related]
3. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.
Wainwright LJ; Lasorella A; Iavarone A
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9396-400. PubMed ID: 11481496
[TBL] [Abstract][Full Text] [Related]
4. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
5. Differential drug sensitivity of human neuroblastoma cells.
Spengler BA; Ross RA; Biedler JL
Cancer Treat Rep; 1986 Aug; 70(8):959-65. PubMed ID: 3731152
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
7. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
8. Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line.
Sadée W; Yu VC; Richards ML; Preis PN; Schwab MR; Brodsky FM; Biedler JL
Cancer Res; 1987 Oct; 47(19):5207-12. PubMed ID: 3040240
[TBL] [Abstract][Full Text] [Related]
9. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid.
Liang Y; Li QF; Zhang XY; Shi SL; Jing GJ
J Cell Biochem; 2009 Apr; 106(5):849-57. PubMed ID: 19160409
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of DAN enhances the retinoic acid-induced neuronal differentiation in human neuroblastoma cell lines.
Nakamura Y; Ozaki T; Ichimiya S; Nakagawara A; Sakiyama S
Biochem Biophys Res Commun; 1998 Feb; 243(3):722-6. PubMed ID: 9500977
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis.
Simpson PB; Bacha JI; Palfreyman EL; Woollacott AJ; McKernan RM; Kerby J
Anal Biochem; 2001 Nov; 298(2):163-9. PubMed ID: 11757502
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity.
Nicolini G; Miloso M; Zoia C; Di Silvestro A; Cavaletti G; Tredici G
Anticancer Res; 1998; 18(4A):2477-81. PubMed ID: 9703895
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
15. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Tieu K; Zuo DM; Yu PH
J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
[TBL] [Abstract][Full Text] [Related]
17. Induction of interleukin-8 expression in neuroblastoma cells by retinoic acid: implication of leukocyte chemotaxis and activation.
Yang KD; Cheng SN; Wu NC; Shaio MF
Pediatr Res; 1993 Dec; 34(6):720-4. PubMed ID: 8108182
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of differentiation inducers in combination on human neuroblastoma cells in vitro.
Rocchi P; Simone G; Lorenzetti A; Granchi D; Paolucci P; Paolucci G
Anticancer Res; 1989; 9(6):1605-9. PubMed ID: 2627114
[TBL] [Abstract][Full Text] [Related]
20. Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines.
Redova M; Chlapek P; Loja T; Zitterbart K; Hermanova M; Sterba J; Veselska R
Int J Mol Med; 2010 Feb; 25(2):271-80. PubMed ID: 20043138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
